MHRA Archives | Dispensing Doctors' Association

Eli Lilly achieves UK first with tablet GLP1

The UK has become the first country in Europe to authorise Eli Lilly’s GLP-1 receptor agonist tablet orforglipron for weight management and type 2 diabetes. While this tablet is approved for use in the UK, it is not a

August 11th 2026

Medicines safety added to English school curriculum

Today (September 17) is World Patient Safety Day To mark the event the UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced that medicine safety and how to report side effects of medicines via the Yellow Card scheme is now

September 17th 2025

MSN survey: Have your say

Dispensing GP teams and other health professionals are asked to give views on the communication of medicine supply notifications (MSNs) are communicated to healthcare professionals. Specialist Pharmacy Services is hosting the survey, which aims to i

February 14th 2025

January 6th 2025

MHRA warns against illegal weight loss drugs

GPs are asked to support the MHRA in its campaign against illegal weight loss medication. The campaign encourages people to speak with their healthcare professional team if they intend to buy a weight-loss medicine. The key message is that supply in

September 9th 2024

New safety advice for valproate use in men

Men taking valproate are being advised to use effective contraception during valproate treatment and for at least three months after stopping valproate. New MHRA safety advice follows research that reports a possible association between valproate us